Status
Conditions
Treatments
About
The purpose of this study is to evaluate subjects with X-linked retinoschisis in a clinical setting to collect data on disease progression.
Full description
The objective of the study is to evaluate subjects with XLRS in a clinical setting and gather data on disease progression. The data from this study will enhance the understanding of the natural history of this rare disease and will facilitate appropriately powered safety studies in a future gene therapy trial in humans.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Main Study:
CAI sub-study:
• Presence of maculoschisis
Exclusion criteria
Main Study:
• Other eye diseases that might affect the results (e.g. history of retinal detachment, glaucoma, cataracts that prohibit imaging, or any other eye pathology that in the opinion of the investigator would preclude enrollment)
CAI Sub-study:
Exclusion Criteria
Any drug-specific contraindication/precaution listed below (from www.micromedex.com):
Topical Eye Drop Dorzolamide Hydrochloride
Contraindications:
• hypersensitivity to dorzolamide products, including sulfa allergies
Precautions:
Topical Eye Drop Brinzolamide
Contraindications:
• hypersensitivity to any component of the product, including sulfa allergies
Precautions:
66 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal